Helixgate https://validator.w3.org/feed/docs/rss2.html AI Identifies Pre-existing Antimicrobial Antibody Profile That May Predict Immune Response to Vaccination Scientists Analyze 267 Receptors That Control Protein Fate in Rare Diseases Regeneron to challenge Ipsen as FDA clears bone disease drug Cancer vaccine win restores Wall Street’s faith in Moderna Scribe’s early-stage IPO standout defies biotech’s derisking trend STAT+: How a Trump loyalist got the FDA nomination STAT+: FDA approves Ultragenyx gene therapy DDII Digital Forum: Resilience, smarter labs, therapeutics, and capital flows STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more Regeneron wins FDA approval to challenge Ipsen for rare bone disease market Built Without Bacteria: Bringing Cell-Free Synthesis to the Bench Ultragenyx bags first gene therapy approval as previously rejected Sanfilippo asset awaits decision Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future Rewriting the rules of CMV prevention STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection Chai tees up Bristol Myers Squibb AI antibody discovery collab Reduce protein to increase longevity? Nutrition experts say that’s a bad idea Out of sight, out of work? What’s driving remote job cuts 7 biopharma M&A deals where layoffs followed Human Multi-Organ Chip Offers New Insight Into Cancer Metastasis Why pediatric rare oncology outperforms in a volatile biotech market Intracellular protein binders for imaging, control and future therapeutics STAT+: How Trump loyalist Heidi Overton became the president’s pick to run the FDA Abundance of Rare Immune Cell Type in Supercentenarians May Help Maintain Healthy Aging STAT+: New CDC director tells staff she is prepared to speak ‘truth to power’ Trump’s FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: analysts Trust in science: A new STAT initiative CAR T Manufacturing Innovation Expands Patient Access Trump nominates policy aide Overton to lead FDA Analysis: What Anthropic’s protein study says about its life-sciences aims STAT+: American Cancer Society cancels alcohol industry fundraiser MindMaze Therapeutics appoints strategic advisor for US growth Gene Switch Uses Electromagnetic Fields to Control Genes Remotely 11 companies hiring in New Jersey Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goal STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more Trump picks White House aide Heidi Overton as FDA chief: reports Dissecting Chinese trial strategy in wake of deaths Pollen has a surprising problem — and honeybees have found a way around it Enveda’s exercise-simulating obesity tablet clears early clinical test 2026 IPO stock tracker: How newly public biotechs are performing She grew up unvaccinated. Now she’s a leading voice for science — and empathy Leadership Lab: The one person executives need by their side Physician group sues Trump administration over dietary guidelines process  Roche pours $750M into Oregon manufacturing plant as obesity push expands Takeda leads wave of orexin drugs with potential to upend narcolepsy market With China rising, Hong Kong builds bridge to biotech innovation STAT+: Trump expected to pick White House adviser Heidi Overton to lead FDA High-throughput synthesis of DNA fragments by molecular self-assembly of overlapping oligonucleotides Home